Androgen deprivation therapy for prostate cancer: indications, contraindications and possible consequences.
Androgen deprivation therapy (ADT) has been the mainstay of palliative treatment in advanced and metastatic prostate cancer for many years. It is also increasingly being used in patients with localized disease. Here we review some recent trials that are providing information on its benefits and disadvantages in different circumstances.
Department of Urology, School of Medicine, University of California-San Francisco 1600 Divisadero Street, San Francisco, CA 94143 USA.
Alexander
A
Karl
Badrinath
B
Konety